| Code | 5001D | ||||||||||
| MA number | EU/1/07/438/009 | ||||||||||
| Product Form: | cps dur 300(3x100)x250 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.02.2008 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC mykofenolat 3 12 2015.pdf
|
| Safety feature | Yes |
| Data update: | 11.07.2023 |
